Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Eli Lilly and Company
Actuate Therapeutics Inc.
City of Hope Medical Center
Tomsk National Research Medical Center of the Russian Academy of Sciences
M.D. Anderson Cancer Center
Hoffmann-La Roche
University of California, Davis
Duke University
AstraZeneca
Poseida Therapeutics, Inc.
City of Hope Medical Center
University of Washington
Incyte Corporation
City of Hope Medical Center
TCR2 Therapeutics
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Cancer Research UK
Milton S. Hershey Medical Center
OncoC4, Inc.
Tempus AI
Cybrexa Therapeutics
Carisma Therapeutics Inc
NGM Biopharmaceuticals, Inc
NantBioScience, Inc.